0000950170-24-071526.txt : 20240610
0000950170-24-071526.hdr.sgml : 20240610
20240610193526
ACCESSION NUMBER: 0000950170-24-071526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fountain Tamara
CENTRAL INDEX KEY: 0001902243
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40587
FILM NUMBER: 241034319
MAIL ADDRESS:
STREET 1: C/O RXSIGHT, INC.
STREET 2: 100 COLUMBIA
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sight Sciences, Inc.
CENTRAL INDEX KEY: 0001531177
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 800625749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (415) 889-0550
MAIL ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
ownership.xml
4
X0508
4
2024-06-06
0001531177
Sight Sciences, Inc.
SGHT
0001902243
Fountain Tamara
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK
CA
94025
true
false
false
false
false
Common Stock
2024-06-06
4
A
false
17366
0.00
A
50437
D
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
Includes (i) 21,086 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 11,985 RSUs granted to the Reporting Person on January 8, 2023, which are subject to vesting as previously reported.
/s/ Jeremy Hayden, Attorney-in-Fact for Tamara Fountain, M.D.
2024-06-10